Aktie A3DWN5 TREX WIND-DOWN, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Trex Wind-down, Inc.

Aktien

A3DWN5

US8870802084

TMBRQ

Markt geschlossen - OTC Markets
Andere Börsenplätze
 17:28:09 09.05.2024 		% 5 Tage % 1. Jan.
0,0001 USD -50,00 % Intraday Chart für Trex Wind-down, Inc. 0,00 % -91,67 %
04.04. Erster Antrag auf Verlängerung der Exklusivitätsfrist für Timber Pharmaceuticals, Inc. bewilligt CI
20.03. Zweite revidierte Offenlegungserklärung und Plan für Timber Pharmaceuticals, Inc. vorläufig genehmigt CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Second Revised Combined Joint Liquidation Plan and Disclosure Statement Approved for Trex Wind-down, Inc.
First Motion for Exclusivity Period Extension Approved For Timber Pharmaceuticals, Inc.
Second Revised Disclosure Statement and Plan Approved on Interim Basis for Timber Pharmaceuticals, Inc.
First Motion for Exclusivity Period Extension Filed by Timber Pharmaceuticals, Inc.
Timber Pharmaceuticals, Inc. Presents Preliminary Results from the ASCEND Trial in A Late-Breaking Session At the 2024 American Academy of Dermatology Annual Meeting
Combined Joint Liquidation Plan & Disclosure Statement Filed by Timber Pharmaceuticals, Inc.
LEO Pharma finalizes acquisition of key assets from Timber Pharmaceuticals
Motion for Asset Sale Approved for Timber Pharmaceuticals, Inc.
LEO Pharma A/S completed the acquisition of Substantially All the assets from Timber Pharmaceuticals, Inc. (OTCPK:TMBR.Q).
Notice of Selection of Winning Bidder & Asset Purchase Agreement Filed for Timber Pharmaceuticals, Inc.
Notice for Auction Cancellation Filed by Timber Pharmaceuticals, Inc.
Bidding Procedure Approved for Timber Pharmaceuticals, Inc.
Final DIP Financing Approved for Timber Pharmaceuticals, Inc.
Timber Pharmaceuticals to Be Delisted From NYSE American
Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market
Timber Pharmaceuticals Receives Court Approval of Motions to Support Business Operations
Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American
Timber Pharmaceuticals, Inc.(NYSEAM:TMBR) dropped from S&P TMI Index
Interim DIP Financing Approved for Timber Pharmaceuticals, Inc.
Motion for Joint Administration Approved for Timber Pharmaceuticals, Inc.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3DWN5 Aktie
  4. Nachrichten Trex Wind-down, Inc.
  5. Andere Sprachen